Bill > H1296

This bill aims to protect 340B drug discount program providers by establishing new regulations for health insurance issuers, pharmacy benefit managers, and other third-party payors. The 340B drug discount program allows certain healthcare organizations to purchase prescription drugs at significantly reduced prices. The bill prohibits these entities from discriminating against 340B providers by implementing several key restrictions: they cannot reimburse 340B entities at lower rates than non-340B entities, impose different terms or conditions, require additional claim submissions or modifications, or prevent patients from choosing 340B pharmacies. The bill also prevents manufacturers and distributors from interfering with 340B drug acquisition or delivery. Specifically, the legislation bars third-party payors from imposing extra fees, reducing dispensing fees, creating network participation restrictions, or requiring special drug identification on claims. Additionally, manufacturers cannot deny or restrict 340B drug delivery to contracted pharmacies. The bill applies to multiple chapters of Massachusetts law, covering various types of health insurance providers, and aims to ensure fair treatment and patient choice in accessing discounted prescription drugs through the 340B program.

Business and Industry

https://malegislature.gov/Bills/194/H1296